Bristol Myers Squibb (BMS) has filed a lawsuit against AstraZeneca, alleging that AstraZeneca’s Imjudo infringes patents from its blockbuster drug Yervoy. The company also sued AstraZeneca last year over another cancer immunotherapy.
Bristol Myers Squibb sues AstraZeneca over alleged patent infringement of cancer drug
